SCHEMBL21118698

SCHEMBL21118698

CNCCC(Oc1ccccc1C(=O)NCCc1ccccc1)c1cccs1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 9/20 0.55
SLC6A4 P31645 9/20 0.55
SLC6A2 P23975 8/20 0.55
GAA P10253 2/20 0.55
KMT2A Q03164 2/20 0.55
MLNR O43193 1/20 0.55
CACNA1F O60840 1/20 0.55
CYP1A2 P05177 1/20 0.55
ADRB1 P08588 1/20 0.55
CYP3A4 P08684 1/20 0.55
HTR1A P08908 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
DRD2 P14416 1/20 0.55
KCNE1 P15382 1/20 0.55
ADRA2B P18089 1/20 0.55
ADRA2C P18825 1/20 0.55
HTR2A P28223 1/20 0.55
HTR2C P28335 1/20 0.55
MC4R P32245 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21118548 0.91 SLC6A3 (0.59) SLC6A3SLC6A4SLC6A2GAAKMT2A
SCHEMBL21118561 0.85 SLC6A2 (0.55) SLC6A3SLC6A4SLC6A2GAAKMT2A
SCHEMBL21118535 0.82 SLC6A2 (0.50) SLC6A3SLC6A4SLC6A2KMT2ACYP1A2
SCHEMBL22714331 0.80 SLC6A4 (0.53) SLC6A3SLC6A4SLC6A2GAAKMT2A
SCHEMBL21118551 0.79 SLC6A3 (0.56) SLC6A3SLC6A4SLC6A2GAAKMT2A
SCHEMBL21118704 0.77 SLC6A3 (0.56) SLC6A3SLC6A4SLC6A2GAAKMT2A
SCHEMBL21118537 0.77 SLC6A2 (0.50) SLC6A3SLC6A4SLC6A2KMT2ACYP1A2
SCHEMBL21118559 0.76 TP53 (0.57) SLC6A3SLC6A4SLC6A2KMT2ACYP1A2
Duloxetine SCHEMBL3335 0.75 SLC6A2 (0.87) SLC6A3SLC6A4SLC6A2GAAKMT2A
Duloxetine SCHEMBL3896385 0.75 SLC6A2 (0.87) SLC6A3SLC6A4SLC6A2GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110137-A1 O-PHENOXY AND O-BENZYLOXYPROPYLAMINO DERIVATIVES HAVING ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2019-06-13 WO disclosed